Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Global Microsphere Injection Market Research Report 2026

Global Microsphere Injection Market Research Report 2026

Industry: Medical Devices & Consumables

Published: 2026-03-11

Pages: 132 Pages

Report ld: 6164211

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global Microsphere Injection market was valued at US$ 209 million in 2025 and is anticipated to reach US$ 302 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Microsphere Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Microsphere Injection Market Size(US$)

M= millions and B=billions

QYRLogo
Microsphere Injection are tiny, spherical particles—typically ranging from a few micrometers to a few hundred micrometers in diameter—designed to be delivered into the body via injection for therapeutic or diagnostic purposes. Made from biocompatible materials such as polymers (e.g., PLGA, gelatin) or ceramics, these microspheres can encapsulate drugs, proteins, or imaging agents, allowing for controlled release, targeted delivery, and reduced side effects. They are widely used in drug delivery systems, cancer therapy, tissue engineering, and cosmetic or aesthetic treatments (like dermal fillers). Their customizable size, composition, and release pr
The North American market for Microsphere Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Microsphere Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Microsphere Injection include Novartis, Ferring, Ipsen, Takeda, Roche, AstraZeneca, OraPharma, Alkermes, Pacira BioSciences, Xian Janssen Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Microsphere Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microsphere Injection. The Microsphere Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Microsphere Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microsphere Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
  • Report Metric

  • Details

  • Report Title

  • Global Microsphere Injection Market Research Report 2026

  • Forecasted Market Size in 2032

  • US$ 302 million

  • CAGR(2026-2032)

  • 5.5%

  • Market Size Available for Years

  • 2026-2032

  • Global Microsphere Injection Companies Covered

  • Novartis

    Ferring

    Ipsen

    Takeda

    Roche

    AstraZeneca

    OraPharma

    Alkermes

    Pacira BioSciences

    Xian Janssen Pharmaceutical

    Shandong Luye Pharmaceutical

    Livzon Pharmaceutical

    Zhejiang Sundoc Pharmaceutical Science and Tech

    Beijing Boente Pharmaceutical

    Guangzhou DiQi Pharmaceuticals

    Qilu Pharmaceutical

    Changchun GeneScience Pharmaceutical

    Anhui BBCA Biochemical

    Yichang Humanwell Pharmaceutical

  • Global Microsphere Injection Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Microsphere Injection Market, Segment by Type

  • Risperidone Microspheres

    Leuprorelin Microspheres

    Octreotide Microspheres

    Triptorelin Microspheres

    Others

  • Global Microsphere Injection Market, Segment by Application

  • Malignant Tumors

    Diabetes

    Cardiovascular Diseases

    Mental Illness

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Microsphere Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Microsphere Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

Table of Contents

1 Microsphere Injection Market Overview
1.1 Product Definition
1.2 Microsphere Injection by Type
1.2.1 Global Microsphere Injection Market Value by Type: 2025 vs 2032
1.2.2 Risperidone Microspheres
1.2.3 Leuprorelin Microspheres
1.2.4 Octreotide Microspheres
1.2.5 Triptorelin Microspheres
1.2.6 Others
1.3 Microsphere Injection by Application
1.3.1 Global Microsphere Injection Market Value by Application: 2025 vs 2032
1.3.2 Malignant Tumors
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Mental Illness
1.3.6 Others
1.4 Global Microsphere Injection Market Size Estimates and Forecasts
1.4.1 Global Microsphere Injection Revenue 2021–2032
1.4.2 Global Microsphere Injection Sales 2021–2032
1.4.3 Global Microsphere Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Microsphere Injection Market Competition by Manufacturers
2.1 Global Microsphere Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Microsphere Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Microsphere Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Microsphere Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Microsphere Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Microsphere Injection, Product Types and Applications
2.7 Global Key Manufacturers of Microsphere Injection, Date of Entry into the Industry
2.8 Global Microsphere Injection Market Competitive Situation and Trends
2.8.1 Global Microsphere Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Microsphere Injection Players Market Share by Revenue
2.8.3 Global Microsphere Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microsphere Injection Market Scenario by Region
3.1 Global Microsphere Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Microsphere Injection Sales by Region: 2021–2032
3.2.1 Global Microsphere Injection Sales by Region: 2021–2026
3.2.2 Global Microsphere Injection Sales by Region: 2027–2032
3.3 Global Microsphere Injection Revenue by Region: 2021–2032
3.3.1 Global Microsphere Injection Revenue by Region: 2021–2026
3.3.2 Global Microsphere Injection Revenue by Region: 2027–2032
3.4 North America Microsphere Injection Market Facts & Figures by Country
3.4.1 North America Microsphere Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Microsphere Injection Sales by Country (2021–2032)
3.4.3 North America Microsphere Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microsphere Injection Market Facts & Figures by Country
3.5.1 Europe Microsphere Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Microsphere Injection Sales by Country (2021–2032)
3.5.3 Europe Microsphere Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microsphere Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Microsphere Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Microsphere Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Microsphere Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Microsphere Injection Market Facts & Figures by Country
3.7.1 Latin America Microsphere Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Microsphere Injection Sales by Country (2021–2032)
3.7.3 Latin America Microsphere Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Microsphere Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Microsphere Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Microsphere Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Microsphere Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microsphere Injection Sales by Type (2021–2032)
4.1.1 Global Microsphere Injection Sales by Type (2021–2026)
4.1.2 Global Microsphere Injection Sales by Type (2027–2032)
4.1.3 Global Microsphere Injection Sales Market Share by Type (2021–2032)
4.2 Global Microsphere Injection Revenue by Type (2021–2032)
4.2.1 Global Microsphere Injection Revenue by Type (2021–2026)
4.2.2 Global Microsphere Injection Revenue by Type (2027–2032)
4.2.3 Global Microsphere Injection Revenue Market Share by Type (2021–2032)
4.3 Global Microsphere Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Microsphere Injection Sales by Application (2021–2032)
5.1.1 Global Microsphere Injection Sales by Application (2021–2026)
5.1.2 Global Microsphere Injection Sales by Application (2027–2032)
5.1.3 Global Microsphere Injection Sales Market Share by Application (2021–2032)
5.2 Global Microsphere Injection Revenue by Application (2021–2032)
5.2.1 Global Microsphere Injection Revenue by Application (2021–2026)
5.2.2 Global Microsphere Injection Revenue by Application (2027–2032)
5.2.3 Global Microsphere Injection Revenue Market Share by Application (2021–2032)
5.3 Global Microsphere Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novartis Microsphere Injection Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Ferring
6.2.1 Ferring Company Information
6.2.2 Ferring Description and Business Overview
6.2.3 Ferring Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Ferring Microsphere Injection Product Portfolio
6.2.5 Ferring Recent Developments/Updates
6.3 Ipsen
6.3.1 Ipsen Company Information
6.3.2 Ipsen Description and Business Overview
6.3.3 Ipsen Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ipsen Microsphere Injection Product Portfolio
6.3.5 Ipsen Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Company Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Takeda Microsphere Injection Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 Roche
6.5.1 Roche Company Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Roche Microsphere Injection Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 AstraZeneca Microsphere Injection Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 OraPharma
6.7.1 OraPharma Company Information
6.7.2 OraPharma Description and Business Overview
6.7.3 OraPharma Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 OraPharma Microsphere Injection Product Portfolio
6.7.5 OraPharma Recent Developments/Updates
6.8 Alkermes
6.8.1 Alkermes Company Information
6.8.2 Alkermes Description and Business Overview
6.8.3 Alkermes Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Alkermes Microsphere Injection Product Portfolio
6.8.5 Alkermes Recent Developments/Updates
6.9 Pacira BioSciences
6.9.1 Pacira BioSciences Company Information
6.9.2 Pacira BioSciences Description and Business Overview
6.9.3 Pacira BioSciences Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Pacira BioSciences Microsphere Injection Product Portfolio
6.9.5 Pacira BioSciences Recent Developments/Updates
6.10 Xian Janssen Pharmaceutical
6.10.1 Xian Janssen Pharmaceutical Company Information
6.10.2 Xian Janssen Pharmaceutical Description and Business Overview
6.10.3 Xian Janssen Pharmaceutical Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Xian Janssen Pharmaceutical Microsphere Injection Product Portfolio
6.10.5 Xian Janssen Pharmaceutical Recent Developments/Updates
6.11 Shandong Luye Pharmaceutical
6.11.1 Shandong Luye Pharmaceutical Company Information
6.11.2 Shandong Luye Pharmaceutical Description and Business Overview
6.11.3 Shandong Luye Pharmaceutical Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shandong Luye Pharmaceutical Microsphere Injection Product Portfolio
6.11.5 Shandong Luye Pharmaceutical Recent Developments/Updates
6.12 Livzon Pharmaceutical
6.12.1 Livzon Pharmaceutical Company Information
6.12.2 Livzon Pharmaceutical Description and Business Overview
6.12.3 Livzon Pharmaceutical Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Livzon Pharmaceutical Microsphere Injection Product Portfolio
6.12.5 Livzon Pharmaceutical Recent Developments/Updates
6.13 Zhejiang Sundoc Pharmaceutical Science and Tech
6.13.1 Zhejiang Sundoc Pharmaceutical Science and Tech Company Information
6.13.2 Zhejiang Sundoc Pharmaceutical Science and Tech Description and Business Overview
6.13.3 Zhejiang Sundoc Pharmaceutical Science and Tech Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Zhejiang Sundoc Pharmaceutical Science and Tech Microsphere Injection Product Portfolio
6.13.5 Zhejiang Sundoc Pharmaceutical Science and Tech Recent Developments/Updates
6.14 Beijing Boente Pharmaceutical
6.14.1 Beijing Boente Pharmaceutical Company Information
6.14.2 Beijing Boente Pharmaceutical Description and Business Overview
6.14.3 Beijing Boente Pharmaceutical Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Beijing Boente Pharmaceutical Microsphere Injection Product Portfolio
6.14.5 Beijing Boente Pharmaceutical Recent Developments/Updates
6.15 Guangzhou DiQi Pharmaceuticals
6.15.1 Guangzhou DiQi Pharmaceuticals Company Information
6.15.2 Guangzhou DiQi Pharmaceuticals Description and Business Overview
6.15.3 Guangzhou DiQi Pharmaceuticals Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Guangzhou DiQi Pharmaceuticals Microsphere Injection Product Portfolio
6.15.5 Guangzhou DiQi Pharmaceuticals Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Company Information
6.16.2 Qilu Pharmaceutical Description and Business Overview
6.16.3 Qilu Pharmaceutical Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Qilu Pharmaceutical Microsphere Injection Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Changchun GeneScience Pharmaceutical
6.17.1 Changchun GeneScience Pharmaceutical Company Information
6.17.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.17.3 Changchun GeneScience Pharmaceutical Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Changchun GeneScience Pharmaceutical Microsphere Injection Product Portfolio
6.17.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
6.18 Anhui BBCA Biochemical
6.18.1 Anhui BBCA Biochemical Company Information
6.18.2 Anhui BBCA Biochemical Description and Business Overview
6.18.3 Anhui BBCA Biochemical Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Anhui BBCA Biochemical Microsphere Injection Product Portfolio
6.18.5 Anhui BBCA Biochemical Recent Developments/Updates
6.19 Yichang Humanwell Pharmaceutical
6.19.1 Yichang Humanwell Pharmaceutical Company Information
6.19.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.19.3 Yichang Humanwell Pharmaceutical Microsphere Injection Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Yichang Humanwell Pharmaceutical Microsphere Injection Product Portfolio
6.19.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microsphere Injection Industry Chain Analysis
7.2 Microsphere Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microsphere Injection Production Mode & Process Analysis
7.4 Microsphere Injection Sales and Marketing
7.4.1 Microsphere Injection Sales Channels
7.4.2 Microsphere Injection Distributors
7.5 Microsphere Injection Customer Analysis
8 Microsphere Injection Market Dynamics
8.1 Microsphere Injection Industry Trends
8.2 Microsphere Injection Market Drivers
8.3 Microsphere Injection Market Challenges
8.4 Microsphere Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Microsphere Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Microsphere Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Microsphere Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Microsphere Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Microsphere Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Microsphere Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Microsphere Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Microsphere Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Microsphere Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Microsphere Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Microsphere Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Microsphere Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Microsphere Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Microsphere Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Microsphere Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Microsphere Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Microsphere Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Microsphere Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Microsphere Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Microsphere Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Microsphere Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Microsphere Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Microsphere Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Microsphere Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Microsphere Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Microsphere Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Microsphere Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Microsphere Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Microsphere Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Microsphere Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Microsphere Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Microsphere Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Microsphere Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Microsphere Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Microsphere Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Microsphere Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Microsphere Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Microsphere Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Microsphere Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Microsphere Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Microsphere Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Microsphere Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Microsphere Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Microsphere Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Microsphere Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Microsphere Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Microsphere Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Microsphere Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Microsphere Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Microsphere Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Microsphere Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Microsphere Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Microsphere Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Microsphere Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Microsphere Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Microsphere Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Microsphere Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Microsphere Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Microsphere Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Microsphere Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Microsphere Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Microsphere Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Microsphere Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Microsphere Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Microsphere Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Microsphere Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Microsphere Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Microsphere Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Novartis Microsphere Injection Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Ferring Company Information
 Table 76. Ferring Description and Business Overview
 Table 77. Ferring Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Ferring Microsphere Injection Product
 Table 79. Ferring Recent Developments/Updates
 Table 80. Ipsen Company Information
 Table 81. Ipsen Description and Business Overview
 Table 82. Ipsen Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Ipsen Microsphere Injection Product
 Table 84. Ipsen Recent Developments/Updates
 Table 85. Takeda Company Information
 Table 86. Takeda Description and Business Overview
 Table 87. Takeda Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Takeda Microsphere Injection Product
 Table 89. Takeda Recent Developments/Updates
 Table 90. Roche Company Information
 Table 91. Roche Description and Business Overview
 Table 92. Roche Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Roche Microsphere Injection Product
 Table 94. Roche Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. AstraZeneca Microsphere Injection Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. OraPharma Company Information
 Table 101. OraPharma Description and Business Overview
 Table 102. OraPharma Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. OraPharma Microsphere Injection Product
 Table 104. OraPharma Recent Developments/Updates
 Table 105. Alkermes Company Information
 Table 106. Alkermes Description and Business Overview
 Table 107. Alkermes Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Alkermes Microsphere Injection Product
 Table 109. Alkermes Recent Developments/Updates
 Table 110. Pacira BioSciences Company Information
 Table 111. Pacira BioSciences Description and Business Overview
 Table 112. Pacira BioSciences Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Pacira BioSciences Microsphere Injection Product
 Table 114. Pacira BioSciences Recent Developments/Updates
 Table 115. Xian Janssen Pharmaceutical Company Information
 Table 116. Xian Janssen Pharmaceutical Description and Business Overview
 Table 117. Xian Janssen Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Xian Janssen Pharmaceutical Microsphere Injection Product
 Table 119. Xian Janssen Pharmaceutical Recent Developments/Updates
 Table 120. Shandong Luye Pharmaceutical Company Information
 Table 121. Shandong Luye Pharmaceutical Description and Business Overview
 Table 122. Shandong Luye Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Shandong Luye Pharmaceutical Microsphere Injection Product
 Table 124. Shandong Luye Pharmaceutical Recent Developments/Updates
 Table 125. Livzon Pharmaceutical Company Information
 Table 126. Livzon Pharmaceutical Description and Business Overview
 Table 127. Livzon Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Livzon Pharmaceutical Microsphere Injection Product
 Table 129. Livzon Pharmaceutical Recent Developments/Updates
 Table 130. Zhejiang Sundoc Pharmaceutical Science and Tech Company Information
 Table 131. Zhejiang Sundoc Pharmaceutical Science and Tech Description and Business Overview
 Table 132. Zhejiang Sundoc Pharmaceutical Science and Tech Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Zhejiang Sundoc Pharmaceutical Science and Tech Microsphere Injection Product
 Table 134. Zhejiang Sundoc Pharmaceutical Science and Tech Recent Developments/Updates
 Table 135. Beijing Boente Pharmaceutical Company Information
 Table 136. Beijing Boente Pharmaceutical Description and Business Overview
 Table 137. Beijing Boente Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Beijing Boente Pharmaceutical Microsphere Injection Product
 Table 139. Beijing Boente Pharmaceutical Recent Developments/Updates
 Table 140. Guangzhou DiQi Pharmaceuticals Company Information
 Table 141. Guangzhou DiQi Pharmaceuticals Description and Business Overview
 Table 142. Guangzhou DiQi Pharmaceuticals Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Guangzhou DiQi Pharmaceuticals Microsphere Injection Product
 Table 144. Guangzhou DiQi Pharmaceuticals Recent Developments/Updates
 Table 145. Qilu Pharmaceutical Company Information
 Table 146. Qilu Pharmaceutical Description and Business Overview
 Table 147. Qilu Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Qilu Pharmaceutical Microsphere Injection Product
 Table 149. Qilu Pharmaceutical Recent Developments/Updates
 Table 150. Changchun GeneScience Pharmaceutical Company Information
 Table 151. Changchun GeneScience Pharmaceutical Description and Business Overview
 Table 152. Changchun GeneScience Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Changchun GeneScience Pharmaceutical Microsphere Injection Product
 Table 154. Changchun GeneScience Pharmaceutical Recent Developments/Updates
 Table 155. Anhui BBCA Biochemical Company Information
 Table 156. Anhui BBCA Biochemical Description and Business Overview
 Table 157. Anhui BBCA Biochemical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Anhui BBCA Biochemical Microsphere Injection Product
 Table 159. Anhui BBCA Biochemical Recent Developments/Updates
 Table 160. Yichang Humanwell Pharmaceutical Company Information
 Table 161. Yichang Humanwell Pharmaceutical Description and Business Overview
 Table 162. Yichang Humanwell Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Yichang Humanwell Pharmaceutical Microsphere Injection Product
 Table 164. Yichang Humanwell Pharmaceutical Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Microsphere Injection Distributors List
 Table 168. Microsphere Injection Customers List
 Table 169. Microsphere Injection Market Trends
 Table 170. Microsphere Injection Market Drivers
 Table 171. Microsphere Injection Market Challenges
 Table 172. Microsphere Injection Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Microsphere Injection
 Figure 2. Global Microsphere Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Microsphere Injection Market Share by Type: 2025 & 2032
 Figure 4. Risperidone Microspheres Product Picture
 Figure 5. Leuprorelin Microspheres Product Picture
 Figure 6. Octreotide Microspheres Product Picture
 Figure 7. Triptorelin Microspheres Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Microsphere Injection Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Microsphere Injection Market Share by Application: 2025 & 2032
 Figure 11. Malignant Tumors
 Figure 12. Diabetes
 Figure 13. Cardiovascular Diseases
 Figure 14. Mental Illness
 Figure 15. Others
 Figure 16. Global Microsphere Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Microsphere Injection Market Size (US$ Million), 2021–2032
 Figure 18. Global Microsphere Injection Sales (K Units), 2021–2032
 Figure 19. Global Microsphere Injection Average Price (US$/Unit), 2021–2032
 Figure 20. Microsphere Injection Report Years Considered
 Figure 21. Microsphere Injection Sales Share by Manufacturers in 2025
 Figure 22. Global Microsphere Injection Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Microsphere Injection Players: Market Share by Revenue in Microsphere Injection in 2025
 Figure 24. Microsphere Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Microsphere Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Microsphere Injection Sales Market Share by Country (2021–2032)
 Figure 27. North America Microsphere Injection Revenue Market Share by Country (2021–2032)
 Figure 28. United States Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Microsphere Injection Sales Market Share by Country (2021–2032)
 Figure 31. Europe Microsphere Injection Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Microsphere Injection Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Microsphere Injection Revenue Market Share by Region (2021–2032)
 Figure 39. China Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. China Taiwan Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Southeast Asia Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Microsphere Injection Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Microsphere Injection Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Colombia Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Microsphere Injection Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Microsphere Injection Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. UAE Microsphere Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Microsphere Injection by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Microsphere Injection by Type (2021–2032)
 Figure 59. Global Microsphere Injection Price (US$/Unit) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Microsphere Injection by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Microsphere Injection by Application (2021–2032)
 Figure 62. Global Microsphere Injection Price (US$/Unit) by Application (2021–2032)
 Figure 63. Microsphere Injection Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed

Description

The global Microsphere Injection market was valued at US$ 209 million in 2025 and is anticipated to reach US$ 302 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Microsphere Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Microsphere Injection are tiny, spherical particles—typically ranging from a few micrometers to a few hundred micrometers in diameter—designed to be delivered into the body via injection for therapeutic or diagnostic purposes. Made from biocompatible materials such as polymers (e.g., PLGA, gelatin) or ceramics, these microspheres can encapsulate drugs, proteins, or imaging agents, allowing for controlled release, targeted delivery, and reduced side effects. They are widely used in drug delivery systems, cancer therapy, tissue engineering, and cosmetic or aesthetic treatments (like dermal fillers). Their customizable size, composition, and release pr
The North American market for Microsphere Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Microsphere Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Microsphere Injection include Novartis, Ferring, Ipsen, Takeda, Roche, AstraZeneca, OraPharma, Alkermes, Pacira BioSciences, Xian Janssen Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Microsphere Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microsphere Injection. The Microsphere Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Microsphere Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microsphere Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Microsphere Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Microsphere Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
den_biaoTiZhungShi

Related Reports

Global Microsphere Injection Market Research Report 2026

Industry: Medical Devices & Consumables

Published: 2026-03-11

Pages: 132 Pages

Report ld: 6164211

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

Online

JOHN WANG

English

English

Offline

HITESH

English

English

Offline

TANG XIN

Japanese

Japanese

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

Offline

DAMON

Chinese

Chinese

Offline

General Email:
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE